Abstract
Vaccinology can be viewed as an application of immunology. The two disciplines arose from a common root in the late nineteenth century, namely investigations of the host response to infectious agents. Emil von Behring, in studying the humoral immune response to the toxin-producing pathogens Clostridium tetani and Corynebacterium diphtheriae, realized the implication of his observation that protection can be transferred with sera from immunized animals (VON BEHRING 1915). In developing the therapeutic strategy of passive vaccination he relied on antibody quantifications developed by Paul Ehrlich (1904). Soon, however, vaccinology and immunology diverged. The vaccines in current use were often developed empirically and virtually independently of the progress made in basic immunology. This approach has now reached its limits. Novel vaccine generations are required for infectious diseases that still cause enormous health problems, and for which vaccines are not yet available. These vaccines can be developed only in the realm of modern immunology. Recent advances in immunology have provided insights into the specific, anti-infective protection and have thereby supplied the tools for selective stimulation of appropriate immune responses K(AUFMANN 1996a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793
Ahmed R, Gray D (1996) Immunological memory and protective immunity: understanding their relation. Science 272:54–60
Aichele P, Bachmann MF, Hengartner H, Zinkernagel RM (1996) Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 152:21–45
Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54:1–78
Beagley KW, Fujihashi K, Lagoo AS, Lagoo-Deenadaylan S, Black CA, Murray AM, Sharmanov AT, Yamamoto M, McGhee JR, Elson CO, Kiyono H (1995) Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J Immunol 154:5611–5619
Beckman EM, Brenner MB (1995) MHC class I-like, class II-like and CD1 molecules: distinct roles in immunity. Immunol Today 16:349–352
Bendelac A (1995) Mouse NK1+ T cells. Curr Opin Immunol 7:367–374
Benham A, Tulp A, Neefjes J (1995) Synthesis and assembly of MHC-peptide complexes. Immunol Today 16:359–362
Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP (1995) Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev 147:5–29
Boon T, Van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725–729
Branch Moody D, Sugita M, Peters PJ, Brenner MB, Porcelli SA (1996) The CD1 restricted T cell response to mycobacteria. Res Immunol 147:550–559
Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H, Bielefeldt Ohmann H (1992) Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major. Science 257:539–542
Camerini V, Panwala C, Kronenberg M (1993) Regional specialization of the mucosal immune system. Intraepithelial lymphocytes of the large intestine have a different phenotype and function than those of the small intestine. J Immunol 151:1765–1776
Carter LL, Dutton RW (1995) Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol 155:1028–1031
Chan AC, Desai DM, Weiss A (1994) The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 12:555–592
Cohen IR, Mor F (1996) Vaccination therapy against autoimmune diseases. In: Kaufmann SHE (ed) Concepts in vaccine development. De Gruyter, Berlin, pp 559–572
Cresswell P (1994) Assembly, transport, and function of MHC class II molecules Annu Rev Immunol 12:259–294
Croitoru K, Bienenstock J (1994) Characteristics and functions of mucosa-associated lymphoid tissue. In: Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienenstock J (eds) Handbook of mucosal immunology. Academic San Diego, pp 141–150
Dinarello CA (1992) Role of interleukin-1 in infectious diseases. Immunol Rev 127:119–146
Ehrlich P (ed) (1904) Gesammelte Arbeiten zur Immunitätsforschung. Hirschwald, Berlin0
Fantry GT, James SPJ (1994) Cell-mediated immunity and mucosal immunity. Curr Opin Gastroenterol 10:365–373
Fauci AS (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384:529–534
Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50–54
Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ (1996) Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 14:591–617
Früh K, Ahn K, Peterson PA (1997) Inhibition of MHC class I antigen presentation by viral proteins. J Exp Med 75:18–27
Germain RN, Margulies DH (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403–450
Germain RN, Castellino F, Han R, Reis e Sousa C, Romagnoli P, Sadegh-Nasseri S, Zhong T-M (1996) Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules. Immunol Rev 151:5–30
Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM (1996) Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 93:12467–12472
Gotschlich EC (1993) Immunity to extracellular bacteria. In: Paul WE (ed) Fundamental immunology. Raven, New York, pp 1287–1308
Guy-Grand D, Vassalli P (1993) Gut intraepithelial T lymphocytes. Curr Opin Immunol 5:247–252
Harty JT, Lenz LL, Bevan MJ (1996) Primary and secondary immune responses to Listeria monocytogenes. Curr Opin Immunol 9:526–530
Hedrick SM, Eidelman FJ (1993) T lymphocyte antigen receptors. In: Paul WE (ed) Fundamental immunology. Raven, New York, pp 383–420
Hellström KE, Hellström I, Chen L (1996) Can costimulated tumor immunity be therapeutically efficacious? Immunol Rev 145:123–145
James SP, Zeitz M (1994) Human gastrointestinal mucosal T cells. In: Ogra PL Lamm ME, McGhee JR, Mestecky J, Strober W, Bienenstock J (eds) Handbook of mucosal immunology. Academic, San Diego, pp 275–285
Janeway CA Jr (1992) The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10:645–674
Kaufmann SHE (1993) Immunity to intracellular bacteria. In: Paul WE (ed) Fundamental immunology. Raven, New York, pp 1251–1286
Kaufmann SHE (ed) (1996a) Concepts in vaccine development. De Gruyter, Berlin
Kaufmann SHE (1996b) γδ and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA 93:2272–2279
Kaufmann SHE, Schoel B (1994) Heat shock proteins as antigens in immunity against infection and self. In: Morimoto RI, Tissières A, Georgopoulos C (eds) The biology of heat shock proteins and molecular chaperones, vol II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 495–531
Kopf M, Le Gros G, Bachmann MF, Lamers MC, Blüthmann H, Köhler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248
Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707–718
Lenz LL Bevan MJ (1996) H2-M3 restricted presentation of Listeria monocytogenesantigens. Immunol Rev 151:107–121
Liszewski MK, Farries TC, Lubin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 61:201–283
Liu C-C, Young LHY, Young JDE (1996) Mechanisms of disease. Lymphocyte mediated cytolysis and disease. N Engl J Med 335:1651–1659
Locksley RM (1996) Immune responses to protozoa. In: Rich RR, Fleisher TA Schwartz BD, Shearer WT, Strober W (eds) Clinical immunology: principles and practice. Mosby Year Book, St Louis, pp 550–560
MacDonald HR (1995) NK1.1+ T cell receptor-αβ+ cells: new clues to their origin, specificity, and function. J Exp Med 182:633–638
Mackay CR (1993) Immunological memory. Adv Immunol 53:217–265
Melian A, Beckman EM, Porcelli SA, Brenner MB (1996) Antigen presentation by CD1 and MHC-encoded class I-Iike molecules. Curr Opin Immunol 8:82–88
Moore KW, O’Garra A, De Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190
Morein B Lövgren K, Cox JH (1996) Modern adjuvants, functional aspects. In. Kaufmann SHE (ed) Concepts in vaccine development. De Gruyter, Berlin, pp 243–264
Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol today 17:138–146
Nataraj C, Brown ML, Poston RM, Shawar SM, Rich RR, Lindahl KF, Kurlander RJ (1996) H2-M3wt-restricted, Listeria monocytogenes specific CD8 T cells recognize a novel, hydrophobic, protease- resistant, periodate sensitive antigen. Int Immunol 8:367–378
Nutman TB (1996) Immune responses to helminth infection. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, Strober W (eds) Clinical immunology: principles and practice. Mosby Year Book, St Louis, pp 561–570
Ozawa H, Aiba S, Nakagawa, Tagami H (1996) Interferon-γand interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol 26:648–652
Pardoll DM (1995) Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399–416
Podack ER, Kupfer A (1991) T-cell effector functions: mechanisms for delivery of cytotoxicity and help. Annu Rev Cell Biol 7: 479–504
Porcelli SA (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 59:1–98
Poussier P, Julius MH (1994) Thymus-independent T cell development and selection in the intestinal epithelium. Annu Rev Immunol 12:521–553
Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381:751–758
Rammensee HG, Falk K, Rötzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213–244
Rammensee HG, Friede T, Stevanoviic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178–228
Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K (1993) Dominance and Crypticity of T cell antigenetic determinants. Annu Rev Immunol 11:729–766
Stavnezer J (1996) Antibody class switching. Adv Immunol 61:79–146
Stuber E, Strober W, Neurath M (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183:693–698
Takatsu K, Takaki S, Hitoshi Y (1994) Interleukin 5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 57:145–190
Tracey KJ, Cerami A (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9:317–343
von Behring E (1915) Gesammelte Abhandlungen. Marcus and Webers, Bonn
Wahl SM (1994) Transforming growth factor β: the good, the bad, and the ugly. J Exp Med 180:1587–1590
Wegener A-MK, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B (1992) The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 68:83–95
York IA, Rock KL (1996) Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14:369–396
Zinkernagel RM (1993) Immunity to viruses. In: Paul WE (ed) Fundamental immunology. Raven, New York, pp 1211–1250
Zinkernagel RM (1996) Immunology taught by viruses. Science 271:173–178
Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H (1996) On immunological memory. Annu Rev Immunol 14:333–367
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kaufmann, S.H.E., Reimann, J. (1999). Immunology of Infection. In: Perlmann, P., Wigzell, H. (eds) Vaccines. Handbook of Experimental Pharmacology, vol 133. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59955-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-59955-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64196-1
Online ISBN: 978-3-642-59955-2
eBook Packages: Springer Book Archive